Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease

被引:9
|
作者
Pannu, Jaibir S. [1 ]
Simpson, Matthew C. [2 ,3 ]
Donovan, Connor L. [4 ]
Boakye, Eric Adjei [5 ]
Mass, Katherine [1 ]
Challapalli, Sai D. [6 ]
Varvares, Mark A. [7 ]
Osazuwa-Peters, Nosayaba [2 ,3 ]
机构
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO USA
[3] St Louis Univ, Canc Ctr, St Louis, MO 63103 USA
[4] Univ Arkansas, Fulbright Coll Arts & Sci, Fayetteville, AR 72701 USA
[5] Southern Illinois Univ, Sch Med, Dept Populat Sci & Policy, Springfield, IL USA
[6] Univ Texas Hlth Sci Ctr Houston, Dept Otorhinolaryngol Head & Neck Surg, McGovern Med Sch, Houston, TX 77030 USA
[7] Harvard Med Sch, Dept Otolaryngol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA
关键词
cancer survival; distant metastatic disease; head and neck cancer; social determinants of health; surveillance; epidemiology; and end results; SQUAMOUS-CELL CARCINOMAS; HEALTH-INSURANCE STATUS; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; MARITAL-STATUS; IMPACT; STAGE; DISPARITIES; DIAGNOSIS; ASSOCIATION;
D O I
10.1002/hed.26284
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background To describe sociodemographic factors associated with head and neck cancer (HNC) survival among patients with distant metastatic disease. Methods We retrospectively analyzed national data for 2889 adult patients with metastatic HNC (2007-2015). We used Fine and Gray competing risks proportional hazard models, stratified by oropharyngeal cancer status, controlled for sociodemographic factors (age, sex, race/ethnicity, marital status, and insurance status), and accounted for multiple testing. Results Median survival time was 11 months (15 months for patients married/partnered; 13 months for patients with non-Medicaid insurance;P< .01). Among patients with oropharyngeal cancer, being married/partnered was associated with lower mortality hazard (sdHR(divorced/separated)= 1.37, 97.5% confidence interval [CI] = 1.07, 1.75; and sdHR(never married)= 1.43, 97.5% CI = 1.14, 1.80), as was having non-Medicaid insurance (sdHR(uninsured)= 1.44, 97.5% CI = 1.02, 2.04). Conclusions Health insurance and marital status are sociodemographic factors associated with survival among HNC patients with distant metastatic disease, especially in oropharyngeal cases.
引用
收藏
页码:2505 / 2515
页数:11
相关论文
共 50 条
  • [1] Psychosocial and physical correlates of survival and relapse in head and neck cancer patients
    Van den Borne, HW
    DeBoer, MF
    Pruyn, JFA
    PSYCHO-ONCOLOGY, 1998, 7 (03) : 169 - 169
  • [2] Survival with distant metastatic disease in head and neck cancer.: A retrospective analysis
    Dietl, B.
    Marienhagen, J.
    Schaefer, C.
    Pohl, F.
    Murthum, T.
    Koelbl, O.
    HNO, 2007, 55 (10) : 785 - 791
  • [3] Tumor Genomics and the Association with Survival in Recurrent/metastatic Head and Neck Cancer Patients
    Arons, D.
    Loginov, A.
    Allor, E.
    Thomas, H.
    Gaykalova, D.
    Mehra, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E75 - E75
  • [4] PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK CANCER: UNDERSTANDING THE BURDEN OF DISEASE
    Baxi, S.
    Sherman, E.
    You, M.
    Bobiak, S.
    VALUE IN HEALTH, 2016, 19 (03) : A168 - A168
  • [5] Quantifying Costs Associated With Survival Among Patients With Head and Neck Cancer
    Sonis, Stephen
    Saunders, Deborah
    Villa, Alessandro
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (03) : 284 - 285
  • [6] Neck Dissection and Survival Among Head and Neck Cancer Patients Undergoing Adjuvant Immunotherapy
    Patel, Aman M.
    Haleem, Afash
    Cowan, Paul T.
    Roden, Dylan F.
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2025, 10 (02):
  • [7] Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer
    Klapheke, Amy
    Yap, Stanley A.
    Pan, Kevin
    Cress, Rosemary D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 308.e19 - 308.e25
  • [8] Expression of RhoC correlates with metastatic disease and survival of prostate cancer patients
    Iiizumi, Megumi
    Bandyopadhyay, Sucharita
    Hirota, Shigeru
    Hosobe, Sadahiro
    Tsukada, Taisei
    Miura, Kunio
    Saito, Ken
    Watabe, Misako
    Furuta, Eiji
    Zhan, Rui
    Pai, Sudha K.
    Mohinta, Sonia
    Watabe, Kounosuke
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Health insurance status and survival among patients with head and neck cancer in Japan
    Takenaka, Yukinori
    Yasui, Toshimichi
    Enomoto, Keisuke
    Miyabe, Haruka
    Morizane, Natsue
    Ashida, Naoki
    Shimizu, Kotaro
    Hirose, Masayuki
    Yamamoto, Yoshifumi
    Uno, Atsuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 517 - 522
  • [10] Depression and survival in head and neck cancer patients
    Rieke, Katherine
    Schmid, Kendra K.
    Lydiatt, William
    Houfek, Julia
    Boilesen, Eugene
    Watanabe-Galloway, Shinobu
    ORAL ONCOLOGY, 2017, 65 : 76 - 82